Drug Type Small molecule drug |
Synonyms NSD 644 |
Target |
Action inhibitors |
Mechanism Dopamine reuptake inhibitors, NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Phase 1 | Germany | - | - |
Central Nervous System Diseases | Phase 1 | - | - | |
Central Nervous System Diseases | Phase 1 | - | - | |
Neuralgia | Phase 1 | Germany | - | - |
Neuralgia | Phase 1 | - | - | |
Neuralgia | Phase 1 | - | - |